Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERLOTINIB vs ESKETAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERLOTINIB vs ESKETAMINE: Safety Overview

Metric ERLOTINIB ESKETAMINE
Total FAERS Reports 22,472 15,132
Deaths Reported 6,791 637
Death Rate 30.2% 4.2%
Hospitalizations 3,693 2,919
Average Patient Age 67.2 yrs 47.8 yrs
% Female Patients 59.8% 67.0%
FDA Approval Date Apr 16, 2020 Mar 5, 2019
Manufacturer Zydus Lifesciences Limited Janssen Pharmaceuticals Inc.
Route ORAL NASAL
Marketing Status Discontinued Prescription